<DOC>
	<DOCNO>NCT01329458</DOCNO>
	<brief_summary>The aim study ass value contrast enhance ultrasound evaluation de novo focal liver lesion clinical practice , prospective multi-center design .</brief_summary>
	<brief_title>Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver Lesions</brief_title>
	<detailed_description>Focal liver lesion ( FLL ) quite frequently discover daily practice routine ultrasound sometimes require use extensive investigation correct diagnosis , thus increase cost duration diagnosis . On hand , due screen strategy patient liver cirrhosis , FLL discover early patient , must evaluate order establish therapeutic strategy ( include transplantation , surgical resection percutaneous echoguided procedure ) . Contrast enhance ultrasound ( CEUS ) use second generation contrast agent relatively new image modality allow characterization FLL allow positive diagnosis base vascular pattern lesion . The advantage method low cost compare image modality fact perform immediately standard abdominal ultrasound , approximately 5 minute CEUS ( total duration investigation ) confident diagnosis obtain . The place CEUS diagnostic algorithm FLL well established . The European Federation Societies Ultrasound Medicine Biology ( EFSUMB ) issue first Guidelines regard use CEUS 2004 , revise 2008 , main indication method present . The purpose study establish value CEUS evaluation de novo FLL clinical practice . The study include patient discover de novo FLL standard ultrasound ultrasound study conclusive positive diagnosis ( patient simple cyst know FLL CEUS follow exclude form study ) . The standard ultrasound follow contrast study use SonoVueÂ® ( Bracco , Italy ) contrast agent . The amount contrast agent document every patient ( depend ultrasound machine use suspected diagnosis ) . The examination perform use dedicate contrast software ultrasound machine use study . The investigator shall also document every patient : indication CEUS study , short history include presence chronic hepatopathies malignancy , ultrasound machine use operator . Each examination last 5 min bolus injection document 4 video file longer 30 second , contain : The standard study , arterial phase , portal phase late phase . Additional loop store whenever consider necessary . A CEUS diagnosis establish base contrast study . This compare final diagnosis establish base available image clinical data : computer tomography , MRI , biopsy , follow information . A CEUS examination consider conclusive , follow contrast , FLL typical enhancement pattern accord EFSUMB guideline , inconclusive enhancement pattern lesion concordance guide . The stored loop also revise different operator . The study design prospective , multi-center approve ethical review board .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Focal Nodular Hyperplasia</mesh_term>
	<criteria>patient diagnose de novo FLL standard ultrasound age &gt; 18 year , male female gender inform consent contrast enhance study patient contraindication contrast enhance study : subject acute cardiac infarction , class III/IV cardiac insufficiency , rhythm disorder pregnant woman Patients diagnosed simple cyst standard ultrasound ( biliary hydatid ) Patients known FLL , example percutaneous treatment , contrast study use follow patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>FLL</keyword>
	<keyword>CEUS</keyword>
	<keyword>SonoVue</keyword>
	<keyword>HCC</keyword>
	<keyword>Liver metastasis</keyword>
	<keyword>Hemangiomas</keyword>
	<keyword>FNH</keyword>
</DOC>